Barreling toward the loss of exclusivity on its blockbuster oncology therapy Keytruda, Merck & Co. has reportedly offered $3 ...

Ayodhya Ram Temple Trust has asked devotees not to travel to Ayodhya for three days unless it's necessary. The Secretary of ...

The initiative saw the participation of volunteers from Malaysia and abroad, with 25 individuals representing Kenanga ...

Nxera previously announced the initiation of the Phase 3 registrational program of NBI-'568 by Neurocrine in May 2025. The ...

The City of Brecksville will pay a Burton firm $4.3 million to resurface a 2 1/4-mile stretch of Brecksville Road from Ohio ...

The Staff Selection Commission has launched the Phase XIII Selection Post Recruitment 2025, offering 2,423 vacancies across ...

Nigeria is witnessing a significant shift in its oil and gas landscape as local companies expand their roles, driving a new ...

Kymera Therapeutics reported positive results from its phase 1 healthy volunteer study using KT-621. Click here to find out ...

Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...

Zai Lab Limited (NASDAQ:ZLAB) and NovoCure Limited (NASDAQ:NVCR) revealed additional data on Saturday from the Phase 3 PANOVA ...

The Sarasota Housing Authority's final phases of Amaryllis Park Place wins partial sign-off from the city's Development ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...